Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The wrong choice creates either unnecessary cost barriers or avoidable medical risks
If side effects become problematic, your healthcare provider can extend the time at your current dose, pause advancement temporarily, or recommend staying at a lower therapeutic level
It is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm, with doses gradually increased over time to minimize gastrointestinal side effects
The search included terms such as small molecule GLP-1 receptor agonists, oral GLP-1 receptor agonists, Danuglipron, Orforglipron, and Aleniglipron. Additionally, information on ongoing clinical trials involving small molecule GLP-1 receptor agonists was retrieved from the ClinicalTrials.gov database using the same keywords
US$ 26.78
US$ 21.31
US$ 25.01
US$ 25.74
US$ 28.26
US$ 20.00
US$ 20.12
